Cargando…
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence
About one-third of people with major depressive disorder (MDD) fail at least two antidepressant drug trials at 1 year. Together with clinical and experimental evidence indicating that the pathophysiology of MDD is multifactorial, this observation underscores the importance of elucidating mechanisms...
Autores principales: | Najjar, Souhel, Pearlman, Daniel M, Devinsky, Orrin, Najjar, Amanda, Zagzag, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220803/ https://www.ncbi.nlm.nih.gov/pubmed/24289502 http://dx.doi.org/10.1186/1742-2094-10-142 |
Ejemplares similares
-
Neurovascular Unit Dysfunction and Blood–Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence
por: Najjar, Souhel, et al.
Publicado: (2017) -
Neuroinflammation and psychiatric illness
por: Najjar, Souhel, et al.
Publicado: (2013) -
A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis
por: Najjar, Souhel, et al.
Publicado: (2018) -
Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein, and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested within a Randomized, Controlled Trial
por: Pearlman, Daniel M., et al.
Publicado: (2014) -
Autoimmune Encephalitis: A Physician’s Guide to the Clinical Spectrum Diagnosis and Management
por: Patel, Arpan, et al.
Publicado: (2022)